120
Participants
Start Date
April 30, 2009
Primary Completion Date
November 30, 2009
Study Completion Date
December 31, 2009
patiromer
Active investigational drug
placebo
placebo
Investigator Site 005, Northport
Investigator Site 104, Prague
Investigator Site 103, Prague
Investigator Site 020, Buffalo
Investigator Site 029, Miami
Investigator Site 031, Port Charlotte
Investigator Site 201, Göttingen
Investigator Site 022, Columbus
Investigator Site 507, Dnipropetrovsk
Investigator Site 018, Minneapolis
Investigator Site 502, Kharkiv
Investigator Site 509, Kharkiv
Investigator Site 009, Peoria
Investigator Site 102, Brno
Investigator Site 202, Heidelberg
Investigator Site 001, Dallas
Investigator Site 019, Salt Lake City
Investigator Site 406, Moscow
Investigator Site 402, Moscow
Investigator Site 403, Moscow
Investigator Site 404, Saint Petersburg
Investigator Site 412, Saint Petersburg
Investigator Site 405, Saint Petersburg
Investigator Site 407, Kemerovo
Investigator Site 409, Barnaul
Investigator Site 605, Tbilisi
Investigator Site 602, Tbilisi
Investigator Site 604, Tbilisi
Investigator Site 603, Tbilisi
Investigator Site 305, Warsaw
Investigator Site 504, Kiev
Investigator Site 506, Kiev
Investigator Site 501, Kiev
Collaborators (1)
Medpace, Inc.
INDUSTRY
Relypsa, Inc.
INDUSTRY